Please login to the form below
EC
This page shows the latest EC news and features for those working in and with pharma, biotech and healthcare.
UPDATE: AZ/Oxford University COVID-19 vaccine gets EU approval
And we will absolutely do exactly as they say.". 1 February 2021: The European Commission (EC) has granted AstraZeneca (AZ) and Oxford University’s COVID-19 vaccine a conditional marketing authorisation
Latest news
-
EU, UK working towards a ‘win-win’ situation to expand COVID-19 vaccine supplies
The European Commission (EC) and the UK issued a joint statement yesterday, announcing that they are working towards a ‘win-win’ situation over COVID-19 vaccine supply issues. ... The EC and UK have been in discussions over what can be done to ensure
-
EU-UK COVID-19 vaccine row continues as export ban discussion looms
Last week, the European Commission’s (EC) president Ursula von der Leyen warned that the EU may halt exports to countries with ‘higher vaccination rates’ if supplies to the EU do ... the plants based in the EU to be delivering to the EU
-
EU considers blocking COVID-19 vaccine exports to the UK
EC president Ursula von der Leyen says she wants "to see reciprocity and proportionality in exports". ... The EC president also said that the bloc is waiting for doses of the AstraZeneca (AZ)/Oxford University vaccine, which are in the EU’s contract
-
EU announces ‘top-up’ of ten million Pfizer/BioNTech vaccines in Q2
The European Commission (EC) announced earlier this week that it has agreed on an accelerated delivery of ten million doses of Pfizer/BioNTech’s COVID-19 vaccine. ... I know how critical Quarter 2 is for the roll-out of our vaccination strategies in
-
WHO backs emergency use of J&J’s one-dose COVID-19 vaccine
authorisation from the European Commission (EC).
More from news
Approximately 15 fully matching, plus 309 partially matching documents found.
Latest Intelligence
-
Strengthening business competition and reducing anti-competitive practices
This appears to be a global trend, not least (from a European perspective) since the European Commission (EC) published its final report in its pharmaceutical sector inquiry in July 2009. ... Settling the score. While the level of financial penalties
-
A new EU in the making, what lies ahead for pharma?
Margrethe Vestager was being tipped as a possible EC President. She has taken a very tough line on competition and IP, which are obviously big issues for pharma, and has taken
-
Tackling a formidable foe
A year ago the company won EC approval for MAVENCLAD, a course of just 20 tablets that tames the body’s immune response system and can be taken on ten consecutive
-
The sound of silence puts the squeeze on generics and biosimilars
EFPIA issued a statement on its position, stating: “The SPC regime is part of the current EC review of incentives.
-
European CTR implementation advances ethical assessment of clinical trials
well as a clear process of selection of a Central ‘EC’ that will be dealing with a trial. ... who would deal with a selection of the appropriate EC, timelines and financial aspects.
More from intelligence
Approximately 0 fully matching, plus 20 partially matching documents found.
Latest appointments
-
CureVac’s CEO appointed to EC High Level Group
Dr Hoerr joins a panel of 15 group members who will advise the EC on how to strengthen support for breakthrough, market-creating innovation in the Horizon 2020 project as well
-
New EC health director general takes office
Prats Monné's appointment was part of a reshuffle of the Commission's senior management by president Jean-Claude Juncker and, in a statement, the EC said the changes were a
-
IMI appoints new chair of scientific committee
Portugal’s Maria Beatriz da Silva Lima to join EC’s collaborative research group. ... the EC and the industry to improve health innovation in Europe.
-
Jonathan Dickinson joins Ariad from BMS
He joins at an important time for Ariad in Europe as it prepares to launch its chronic myeloid leukaemia treatment Iclusig (ponatinib), pending approval from the European Commission (EC).
-
Tonio Borg nominated to replace John Dalli as EC Health Commissioner
Candidacy of the Maltese deputy prime minister and minister of foreign affairs accepted by Barroso
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences
-
Will COVID-19 necessitate a change in thinking around clinical trials?
The challenge with any clinical study is that every site visit is dictated by the protocol, which has been EC/IRB approved. ... will need to be reported for EC/IRB approvals.
-
Fake News is Bad for your Health
Viral misinformation. Nature, 16 October 2018. http://www.nature.com/articles/d41586-018-07034-4?
-
Rare Disease Day 2019: A patient perspective on primary sclerosing cholangitis
Goode EC, Clark AB, Mells GM et al. Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system.
-
Ensuring quality in medical translation when working ‘blind’
There is also often the need for a review by an Ethics Committee (EC), which can remove some errors, but can introduce spelling or grammar errors too. ... Any EC or client changes should be sent back to the original translators to be checked again.
More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Account Management
-
Competitive Salary Offered
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Senior Content Editor - Biotechnology
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- AbbVie’s Rinvoq has ‘marginal clinical benefit’ over Humira at increased cost, says ICER
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Virtual congresses: video thrilled the cardio tsar
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- CureVac expands COVID-19 vaccine trial protocol to include variant specification
- US pauses rollout of J&J’s COVID-19 vaccine amid reports of rare blood clots
- Lilly’s RET inhibitor Retevmo shows early promise in new cancer types
- Oxford study finds standard asthma medication improves recovery time in COVID-19 patients
- FDA approves new self-injection administration for Xolair
- Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients
- Scientific meetings: leveraging on-site, virtual, on-demand and enduring materials
PMHub
Apex.co.uk Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...
Latest intelligence
- Want to give perfect client service? Tough luck, you’re human
- In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
- WHITE PAPER: Why do men die younger?
- It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
- 3 tips to show patient diversity in your clinical trial materials
- Here are some useful tips to help get your hands on authentically diverse stock photos....
Quick links
Infographics
